Related Experiment Videos
Molecular cloning and characterization of chick CD9
1Division of Cell Biology, Kurume University, Japan.
The Kurume Medical Journal
|August 19, 2000
Summary
Researchers isolated a chick CD9 glycoprotein, finding it shares 63.3% similarity with human CD9. Unlike human and monkey CD9, chick CD9 does not enhance diphtheria toxin binding, offering insights into this mechanism.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- CD9 is a transmembrane glycoprotein crucial for cell adhesion, migration, growth signaling, and tumor cell metastasis.
- Understanding CD9's function and regulatory mechanisms is vital for cancer research and therapeutic development.
Purpose of the Study:
- To isolate and characterize a chick CD9 cDNA clone.
- To compare the chick CD9 sequence with its human counterpart.
- To investigate the role of CD9 in regulating diphtheria toxin (DT) binding activity of human heparin-binding EGF-like growth factor.
Main Methods:
- Isolation of a CD9 cDNA clone from a chick cDNA library.
- Deduction of the amino acid sequence from the chick CD9 open reading frame.
- Sequence comparison between chick CD9 and human/monkey CD9.
- Assay to evaluate the effect of CD9 on diphtheria toxin binding activity.
Main Results:
- A chick CD9 cDNA clone encoding 224 amino acids was successfully isolated.
- The deduced amino acid sequence of chick CD9 exhibits 63.3% identity to human CD9.
- Chick CD9 does not upregulate the diphtheria toxin binding activity of human heparin-binding EGF-like growth factor, unlike human and monkey CD9.
Conclusions:
- The study provides a molecular characterization of chick CD9.
- Sequence differences between chick and human CD9 may explain the differential regulation of diphtheria toxin binding.
- Further investigation into these sequence variations can elucidate the CD9-mediated upregulation mechanism.